General MedicationsORALGeneric
ERTUGLIFLOZIN
ERTUGLIFLOZIN
Standard Dose
15MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview ERTUGLIFLOZIN is listed in Drugs@FDA under application 217071 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ERTUGLIFLOZIN Form and strength TABLET;ORAL - 15MG Sponsor HETERO LABS LTD V Submission history Latest submission status date: 2024-09-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview ERTUGLIFLOZIN is listed in Drugs@FDA under application 217071 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ERTUGLIFLOZIN Form and strength TABLET;ORAL - 15MG Sponsor HETERO LABS LTD V Submission history Latest submission status date: 2024-09-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.